Innovative Rapid Diagnostic Tool for Identifying Pathogens and Assessing Antimicrobial Resistance: Clinical Application in ICU Patients with Sepsis - Takeaways - MDSpire

Innovative Rapid Diagnostic Tool for Identifying Pathogens and Assessing Antimicrobial Resistance: Clinical Application in ICU Patients with Sepsis

  • By

  • Agata Chalasiewicz

  • Jakub Śmiechowicz

  • Patrycja Trzeciak

  • Ewa Lewczyk

  • Waldemar Goździk

  • Barbara Adamik

  • February 27, 2026

  • 0 min

Share

  • 1

    Early diagnosis and treatment of sepsis are critical, as delays increase mortality risk.

  • 2

    Traditional culture methods for pathogen identification take 2 to 5 days, delaying appropriate antibiotic therapy.

  • 3

    The Accelerate Pheno system was evaluated for its ability to rapidly identify pathogens and assess antimicrobial susceptibility.

  • 4

    The study aimed to determine the concordance between the rapid diagnostic system and standard microbiological methods.

  • 5

    Results from the rapid system could impact clinical decisions regarding antimicrobial therapy in septic patients.

Original Source(s)

Innovative Rapid Diagnostic Tool for Identifying Pathogens and Assessing Antimicrobial Resistance: Clinical Application in ICU Patients with Sepsis

  • by Agata Chalasiewicz, Jakub Śmiechowicz, Patrycja Trzeciak, Ewa Lewczyk, Waldemar Goździk, Barbara Adamik

  • February 27, 2026

Related Content

Diagnostic performance of interleukin-27 and C-reactive protein in neonatal sepsis: an updated systematic review and meta-analysis

Elevated plasma cholesterol improves sepsis outcome by promoting hepatic metabolic reprogramming

Evaluation of ambulance blood cultures in patients with suspected sepsis. A rural prospective cohort study